Losartan vs lisinopril efficacy
Pro Research Analysisby 
Searched over 200M research papers
Blood Pressure Lowering Efficacy: Losartan vs Lisinopril
Several studies have directly compared the blood pressure-lowering effects of losartan (an angiotensin receptor blocker, ARB) and lisinopril (an angiotensin-converting enzyme inhibitor, ACEI). In randomized trials, both drugs significantly reduced systolic and diastolic blood pressure in patients with hypertension, with some studies showing similar efficacy between the two medications in achieving target blood pressure levels . However, other studies found that lisinopril may provide a slightly greater reduction in blood pressure and pulse pressure compared to losartan, especially when measured at home or with ambulatory monitoring, rather than in the clinic 27.
Efficacy in Special Populations: Cardiomyopathy and Kidney Disease
In boys with Duchenne muscular dystrophy and newly diagnosed cardiomyopathy, both lisinopril and losartan led to significant and similar improvements in heart function (measured by ejection fraction) over one year, with no difference in efficacy between the two drugs .
For patients with type 2 diabetes and microalbuminuria, both losartan and lisinopril significantly reduced microalbuminuria, and there was no statistically significant difference in their efficacy for this outcome . In children with mild IgA nephropathy, lisinopril alone was as effective as the combination of lisinopril and losartan in reducing proteinuria, suggesting no added benefit from combining the two drugs in this setting . In adults with significant proteinuria, combination therapy (lisinopril plus losartan) reduced proteinuria more than losartan alone, but the difference compared to high-dose losartan was small, and high-dose losartan was better tolerated 89.
Additional Effects: Insulin Sensitivity and Myocardial Perfusion
Lisinopril has been shown to improve insulin sensitivity in non-diabetic hypertensive patients, while losartan did not have a significant effect on this parameter . In patients with hypertension and left ventricular hypertrophy, lisinopril improved myocardial perfusion reserve, whereas losartan did not, suggesting a possible advantage of lisinopril in repairing coronary microvascular function in this population .
Tolerability and Side Effects
Both drugs are generally well tolerated, but side effect profiles differ. Lisinopril is associated with a higher incidence of cough, while losartan tends to have fewer side effects overall . Combination therapy may increase the risk of side effects compared to monotherapy .
Conclusion
Lisinopril and losartan are both effective for lowering blood pressure and reducing proteinuria in various patient populations, with similar efficacy in many settings 14610. Lisinopril may offer additional benefits in improving insulin sensitivity and myocardial perfusion in certain patients 35, but is more likely to cause cough. Losartan is often better tolerated. The choice between these medications may depend on individual patient characteristics, comorbidities, and tolerance to side effects. Combination therapy or higher dosing may provide incremental benefits in proteinuria reduction, but with increased risk of adverse effects 89.
Sources and full results
Most relevant research papers on this topic